Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Sentinel Group Strengthens Growth Strategy with Two Senior Leadership Appointments

April 13, 2026

MOVATI Athletic Opens Fourth Edmonton Location at Harvest Hills Market

April 13, 2026

Lahontan Reports Cyanide Recoveries of 81% for Gold and 60% for Silver at West Santa Fe

April 13, 2026

Keys to Succeed in the Booming $300 Million Optical Genome Mapping Market 2026-2030: Bionano Genomics, 10x Genomics, and Oxford Nanopore Technologies Lead

April 13, 2026

Lambton College shooting: Multiple arrests made, search for main suspect ongoing

April 13, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » NANO Nuclear to Participate in Upcoming Investor and Industry Events
Press Release

NANO Nuclear to Participate in Upcoming Investor and Industry Events

By News RoomApril 13, 20266 Mins Read
NANO Nuclear to Participate in Upcoming Investor and Industry Events
Share
Facebook Twitter LinkedIn Pinterest Email

New York, N.Y., April 13, 2026 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor (MMR) and technology company focused on developing clean energy solutions, today announced its participation in several upcoming investor and industry events.

  • Centri Capital Conference

April 14, 2026 | Nasdaq MarketSite, New York City, NY.

  • A NANO Nuclear executive will participate in a panel discussion titled “The Nuclear Reset: How Advanced Nuclear Is Reshaping Energy Markets,” scheduled at 10:45am ET.
  • The Economist Nuclear Summit

April 15, 2026 | New York City, NY.

  • James Walker, Chief Executive Officer of NANO Nuclear, will lead a talk on “Powering the Electrified Economy: The Race for Clean Power,” scheduled at 9:50am BST/4:50am ET.
  • NANO Nuclear, the Nuclear Summit’s Platinum Sponsor, will host an interactive roundtable discussion titled “Building the Nuclear Supply Chain We Don’t Have: The Micro-Reactor Manufacturing Challenge,” featuring CEO James Walker scheduled at 11:15am BST/6:15am ET.
  • Additionally, CEO James Walker will participate in a panel discussion titled “Atoms as Assets: Making Nuclear Power Investable,” to be held at 2:30pm BST/9:30am ET.

Figure 1 – NANO Nuclear Chief Executive Officer Will Participate in Multiple Speaking Engagements at The Economist Nuclear Summit on April 15th, 2026.

  • A.G.P.’s Security of Supply Chains: Critical Minerals & Energy Virtual Conference

April 15, 2026 | Virtual

About NANO Nuclear Energy Inc.

NANO Nuclear Energy Inc. (NASDAQ: NNE) is a North American advanced technology-driven nuclear energy company seeking to become a commercially focused, diversified, and vertically integrated company across five business lines: (i) cutting edge portable and other microreactor technologies, (ii) nuclear fuel fabrication, (iii) nuclear fuel transportation, (iv) nuclear applications for space and (v) nuclear industry consulting services. NANO Nuclear believes it is the first portable nuclear microreactor company to be listed publicly in the U.S.

Led by a world-class nuclear engineering team, NANO Nuclear’s reactor products in development include its lead project, the patented KRONOS MMR™ Energy System, a stationary high-temperature gas-cooled reactor that is in construction permit pre-application engagement with the U.S. Nuclear Regulatory Commission (NRC) in collaboration with University of Illinois Urbana-Champaign (U. of I.), ZEUS™, a solid core battery reactor, and the space focused, portable LOKI MMR™, each representing advanced developments in clean energy solutions that are modular, on-demand capable, advanced nuclear microreactors.

Advanced Fuel Transportation Inc. (AFT), a NANO Nuclear subsidiary, is led by former executives from the largest transportation company in the world aiming to build a North American transportation company that will provide commercial quantities of HALEU fuel to small modular reactors, microreactor companies, national laboratories, military, and U.S. Department of Energy programs. Through NANO Nuclear, AFT is the exclusive licensee of a patented high-capacity HALEU fuel transportation basket developed by three major U.S. national nuclear laboratories and funded by the Department of Energy. Assuming development and commercialization, AFT is expected to form part of the only vertically integrated nuclear fuel business of its kind in North America.

HALEU Energy Fuel Inc. (HEF), a NANO Nuclear subsidiary, is focusing on the future development of a domestic source for a High-Assay, Low-Enriched Uranium (HALEU) fuel fabrication pipeline for NANO Nuclear’s own microreactors as well as the broader advanced nuclear reactor industry.

NANO Nuclear Space Inc. (NNS), a NANO Nuclear subsidiary, is exploring the potential commercial applications of NANO Nuclear’s developing micro nuclear reactor technology in space. NNS is focusing on applications such as the LOKI MMR™ system and other power systems for extraterrestrial projects and human sustaining environments, and potentially propulsion technology for long haul space missions. NNS’ initial focus will be on cis-lunar applications, referring to uses in the space region extending from Earth to the area surrounding the Moon’s surface.

For more corporate information please visit: https://NanoNuclearEnergy.com/

For further NANO Nuclear information, please contact:
Email: [email protected]
Business Tel: (212) 634-9206

PLEASE FOLLOW OUR SOCIAL MEDIA PAGES HERE:
NANO Nuclear Energy LINKEDIN
NANO Nuclear Energy YOUTUBE
NANO Nuclear Energy X PLATFORM

Cautionary Note Regarding Forward Looking Statements

This news release, each of the investor events referred to herein and statements of NANO Nuclear’s management in connection with this news release and such investor events contain or may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “explore,” “aim,” “plans”, “believes”, “potential”, “will”, “should”, “could”, “would” or “may” and other words of similar meaning. Specifically, forward-looking statements will include those related to NANO Nuclear’s development, construction, demonstration, regulatory licensing and commercial plans and strategies and other future plans and intentions. These and other forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors, which may be beyond our control. For NANO Nuclear, particular risks and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements include but are not limited to the following: (i) risks related to our U.S. Department of Energy (“DOE”), Canadian Nuclear Safety Commission (“CNSC”) or related state or non-U.S. nuclear licensing submissions, (ii) risks related to our vertical integration strategy and the development of new or advanced technology and the acquisition of complimentary technology or businesses, including difficulties with design and testing, cost overruns, regulatory delays, integration issues and the development of competitive technology, (iii) our ability to obtain contracts and funding to be able to continue operations, (iv) risks related to uncertainty regarding our ability to technologically develop and commercially deploy a competitive advanced nuclear reactor or other technology in the timelines we anticipate, if ever, (v) risks related to the impact of U.S. and non-U.S. government regulation, policies and licensing requirements, including by the DOE, the U.S. Nuclear Regulatory Commission, including those associated with the recently enacted ADVANCE Act and the May 23, 2025 Executive Orders seeking to streamline nuclear regulation, as well as the CNSC, and (vi) similar risks and uncertainties associated with the operating an early stage business a highly regulated and rapidly evolving industry. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement, and NANO Nuclear therefore encourages investors to review other factors that may affect future results in its filings with the SEC, which are available for review at www.sec.gov and at https://ir.nanonuclearenergy.com/financial-information/sec-filings. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Sentinel Group Strengthens Growth Strategy with Two Senior Leadership Appointments

MOVATI Athletic Opens Fourth Edmonton Location at Harvest Hills Market

Lahontan Reports Cyanide Recoveries of 81% for Gold and 60% for Silver at West Santa Fe

Keys to Succeed in the Booming $300 Million Optical Genome Mapping Market 2026-2030: Bionano Genomics, 10x Genomics, and Oxford Nanopore Technologies Lead

B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Report 2026 – Worth $18.75 Billion in 2026, the Market is Expected to Reach $44.29 Billion by 2030

Small Molecule Innovator API CDMO Market Outlook, 2026-2033 – Lonza Group, Novo Holdings (Catalent) and Thermo Fisher Scientific Lead the Growing Industry

Healthcare Marketing & Communications Market Report 2026-2032: Align Marketing, Regulatory, and Commercial Initiatives Within Rapidly Evolving Healthcare Markets

Wearable ECG Monitors Industry to More Than Double During 2026-2030, Exceeding $13.6 Billion Total Revenue – Rising Demand for AI-Driven Diagnostics and Home-Based Cardiac Monitoring

Trends & Strategies Shaping the $3.4 Billion Smart Waste Management Industry, 2026-2030

Editors Picks

MOVATI Athletic Opens Fourth Edmonton Location at Harvest Hills Market

April 13, 2026

Lahontan Reports Cyanide Recoveries of 81% for Gold and 60% for Silver at West Santa Fe

April 13, 2026

Keys to Succeed in the Booming $300 Million Optical Genome Mapping Market 2026-2030: Bionano Genomics, 10x Genomics, and Oxford Nanopore Technologies Lead

April 13, 2026

Lambton College shooting: Multiple arrests made, search for main suspect ongoing

April 13, 2026

Latest News

B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Report 2026 – Worth $18.75 Billion in 2026, the Market is Expected to Reach $44.29 Billion by 2030

April 13, 2026

Small Molecule Innovator API CDMO Market Outlook, 2026-2033 – Lonza Group, Novo Holdings (Catalent) and Thermo Fisher Scientific Lead the Growing Industry

April 13, 2026

Healthcare Marketing & Communications Market Report 2026-2032: Align Marketing, Regulatory, and Commercial Initiatives Within Rapidly Evolving Healthcare Markets

April 13, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version